Investing.com -- Shares of Allurion Technologies (NYSE: ALUR) skyrocketed by 350% following the company's announcement of its plans to initiate a clinical study aimed at optimizing muscle mass during ...

Looking further ahead, BofA lowered its iPhone sales forecasts for fiscal 2025 and 2026 to 229 million and 246 million units, ...

Novo Nordisk's phase 1b/2a clinical trial results revealed that their investigational drug, amycretin, led to an average ...

Oil prices are now fairly valued, so for the price to continue to move higher in the short term, we need to see continued ...

American Express Company reported fourth-quarter earnings that surpassed analyst expectations, but shares slipped 1.1% ...

Investing.com -- Verizon (NYSE: VZ) on Friday reported better-than-expected earnings and revenue for the fiscal fourth ...

European markets have received a positive lead-in from Wall Street, where the benchmark S&P 500 index hit a record high after ...

Investing.com - The US dollar has been on a tear since its late-September 2024 lows, and UBS thinks this near-term strength ...

Investing.com - Copenhagen-listed shares in Novo Nordisk (CSE: NOVOb) surged on Friday after the Danish drugmaker said ...

Jefferies reiterates a "buy" rating for Renault, citing strategic advancements such as improved governance, efficient capital ...

The British Pound extended gains against the Dollar and closed a deficit against the Euro after survey data showed the UK ...

British business growth saw a slight uptick in early 2025, however, hiring and business optimism continued to shrink, according to a recent survey. This trend highlights the ongoing challenges faced ...